UB Paderborn / Katalog / Suche / in CDI

Optimization of a Novel Binding Motif to (E)‑3-(3,5-Difluoro-4-((1R,3R)‑2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro‑1H‑pyrido[3,4‑b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist

Journal of medicinal chemistry, 2015-10, Vol.58 (20), p.8128-8140

2015

Volltextzugriff (PDF)

Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology

Journal of medicinal chemistry, 2023-01, Vol.66 (1), p.384-397

2023

Volltextzugriff (PDF)

A combined spectroscopic and crystallographic approach to probing drug–human serum albumin interactions

Bioorganic & medicinal chemistry, 2010-11, Vol.18 (21), p.7486-7496

2010

Volltextzugriff (PDF)

Machine learning meets mechanistic modelling for accurate prediction of experimental activation energies

Chemical science (Cambridge), 2021-01, Vol.12 (3), p.1163-1175

2021

Volltextzugriff (PDF)

Why Do Some Molecules Form Hydrates or Solvates?

Crystal growth & design, 2018-03, Vol.18 (3), p.1903-1908

2018

Volltextzugriff (PDF)

Scaffold Hopping Using Clique Detection Applied to Reduced Graphs

Journal of chemical information and modeling, 2006-03, Vol.46 (2), p.503-511

2006

Volltextzugriff (PDF)

An Intramolecular Diels–Alder Approach to the Isoindolinone Core of AZD8154

Organic process research & development, 2024-06, Vol.28 (6), p.2284-2295

2024

Volltextzugriff (PDF)

Solubility prediction from first principles: a density of states approach

Physical chemistry chemical physics : PCCP, 2018, Vol.2 (32), p.2981-2987

2018

Volltextzugriff (PDF)

Artificial intelligence and automation in computer aided synthesis planning

Reaction chemistry & engineering, 2021-01, Vol.6 (1), p.27-51

2021

Volltextzugriff (PDF)

AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models

Cancer research (Chicago, Ill.), 2016-06, Vol.76 (11), p.3307-3318

2016

Volltextzugriff (PDF)

Distortion/interaction analysis via machine learning

Digital discovery, 2024-10

2024

Volltextzugriff (PDF)

Discovery of 4‑Amino‑N‑[(1S)‑1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H‑pyrrolo[2,3‑d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases

Journal of medicinal chemistry, 2013-03, Vol.56 (5), p.2059-2073

2013

Volltextzugriff (PDF)

Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRAS G12C Inhibitor

Journal of organic chemistry, 2022-02, Vol.87 (4), p.2075-2086

2022

Volltextzugriff (PDF)

Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRASG12C Inhibitor

Journal of organic chemistry, 2022-02, Vol.87 (4), p.2075-2086

2022

Volltextzugriff (PDF)

Tricyclic IndazolesA Novel Class of Selective Estrogen Receptor Degrader Antagonists

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1593-1608

2019

Volltextzugriff (PDF)

The Global Characterisation of a Drug-Dendrimer Conjugate - PEGylated poly-lysine Dendrimer

Journal of pharmaceutical sciences, 2023-03, Vol.112 (3), p.844-858

2023

Volltextzugriff (PDF)

Machine learning reaction barriers in low data regimes: a horizontal and diagonal transfer learning approach

Digital discovery, 2023-08, Vol.2 (4), p.941-951

2023

Volltextzugriff (PDF)

Automated QSAR with a Hierarchy of Global and Local Models

Molecular informatics, 2011-12, Vol.30 (11-12), p.960-972

2011

Volltextzugriff (PDF)

Abstract 3650: Discovery of the clinical candidate AZD9496: a potent and orally bioavailable selective estrogen receptor downregulator and antagonist

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3650-3650

2015

Volltextzugriff (PDF)

Abstract DDT01-03: Discovery and pre-clinical pharmacology of AZD9496: An oral, selective estrogen receptor down-regulator (SERD)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.DDT01-03-DDT01-03

2015

Volltextzugriff (PDF)

Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor

Bioorganic & medicinal chemistry letters, 2012-06, Vol.22 (12), p.4163-4168

2012

Volltextzugriff (PDF)

Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo

Bioorganic & medicinal chemistry letters, 2009-12, Vol.19 (23), p.6670-6674

2009

Volltextzugriff (PDF)

Abstract 3912: The discovery of AZD4547: An orally bioavailable, potent and selective N-(5-Pyrazolyl)benzamide FGFR1-3 inhibitor

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3912-3912

2012

Volltextzugriff (PDF)

Theoretical investigations of conformational aspects of polymorphism. Part 1: o-acetamidobenzamide

Journal of the Chemical Society, Perkin Transactions 2, 1998 (4), p.763-772

1998

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Optimization of a Novel Binding Motif to (E)‑3-(3,5-Difluoro-4-((1R,3R)‑2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro‑1H‑pyrido[3,4‑b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist

Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology

A combined spectroscopic and crystallographic approach to probing drug–human serum albumin interactions

Machine learning meets mechanistic modelling for accurate prediction of experimental activation energies

Why Do Some Molecules Form Hydrates or Solvates?

Scaffold Hopping Using Clique Detection Applied to Reduced Graphs

An Intramolecular Diels–Alder Approach to the Isoindolinone Core of AZD8154

Solubility prediction from first principles: a density of states approach

Artificial intelligence and automation in computer aided synthesis planning

AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models

Distortion/interaction analysis via machine learning

Discovery of 4‑Amino‑N‑[(1S)‑1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H‑pyrrolo[2,3‑d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases

Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRAS G12C Inhibitor

Exploration of a Nitromethane-Carbonylation Strategy during Route Design of an Atropisomeric KRASG12C Inhibitor

Tricyclic IndazolesA Novel Class of Selective Estrogen Receptor Degrader Antagonists

The Global Characterisation of a Drug-Dendrimer Conjugate - PEGylated poly-lysine Dendrimer

Machine learning reaction barriers in low data regimes: a horizontal and diagonal transfer learning approach

Automated QSAR with a Hierarchy of Global and Local Models

Abstract 3650: Discovery of the clinical candidate AZD9496: a potent and orally bioavailable selective estrogen receptor downregulator and antagonist

Abstract DDT01-03: Discovery and pre-clinical pharmacology of AZD9496: An oral, selective estrogen receptor down-regulator (SERD)

Optimization of a Novel Binding Motif to ( E )-3-(3,5-Difluoro-4-((1 R ,3 R )-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1 H -pyrido[3,4- b ]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist

Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor

Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo

Abstract 3912: The discovery of AZD4547: An orally bioavailable, potent and selective N-(5-Pyrazolyl)benzamide FGFR1-3 inhibitor

Theoretical investigations of conformational aspects of polymorphism. Part 1: o-acetamidobenzamide

Suchergebnisse filtern